194 related articles for article (PubMed ID: 6487362)
21. Relationship of binding of a calcium channel blocker to inhibition of contraction in intact cultured embryonic chick ventricular cells.
Marsh JD; Loh E; Lachance D; Barry WH; Smith TW
Circ Res; 1983 Oct; 53(4):539-43. PubMed ID: 6313249
[TBL] [Abstract][Full Text] [Related]
22. Phosphorylation of ventricular sarcolemmal membranes does not alter binding properties of nitrendipine.
Hayes JS; Bowling N; Conery BG; Kauffman RF
Biochim Biophys Acta; 1985 Jan; 812(2):313-20. PubMed ID: 3155624
[TBL] [Abstract][Full Text] [Related]
23. Specific high affinity binding of the calcium channel antagonist, [3H]nitrendipine, to rat liver microsomes.
Gopalakrishnan V; Triggle CR
Can J Physiol Pharmacol; 1984 Sep; 62(9):1249-52. PubMed ID: 6498637
[TBL] [Abstract][Full Text] [Related]
24. Photoaffinity labelling of a 33-35,000 dalton protein in cardiac, skeletal and smooth muscle membranes using a new 125I-labelled 1,4-dihydropyridine calcium channel antagonist.
Sarmiento JG; Epstein PM; Rowe WA; Chester DW; Smilowitz H; Wehinger E; Janis RA
Life Sci; 1986 Dec; 39(25):2401-9. PubMed ID: 2432371
[TBL] [Abstract][Full Text] [Related]
25. [3H]-Nitrendipine, a potent calcium antagonist, binds with high affinity to cardiac membranes.
Bellemann P; Ferry D; Lübbecke F; Glossman H
Arzneimittelforschung; 1981; 31(12):2064-7. PubMed ID: 7199299
[TBL] [Abstract][Full Text] [Related]
26. Specific binding of [3H]d-cis-diltiazem to cardiac sarcolemma and its inhibition by calcium.
Balwierczak JL; Schwartz A
Eur J Pharmacol; 1985 Oct; 116(1-2):193-4. PubMed ID: 2932342
[No Abstract] [Full Text] [Related]
27. The binding of [3H]nitrendipine to receptors for calcium channel antagonists in the heart, cerebral cortex, and ileum of rats.
Ehlert FJ; Roeske WR; Itoga E; Yamamura HI
Life Sci; 1982 Jun; 30(25):2191-202. PubMed ID: 7109844
[TBL] [Abstract][Full Text] [Related]
28. A calcium antagonist drug binding site in skeletal muscle sarcoplasmic reticulum: evidence for a calcium channel.
Fairhurst AS; Thayer SA; Colker JE; Beatty DA
Life Sci; 1983 Mar; 32(12):1331-9. PubMed ID: 6300579
[TBL] [Abstract][Full Text] [Related]
29. Effects of bepridil and diltiazem on [3H]nitrendipine binding to canine cardiac sarcolemma. Potentiation of pharmacological effects of nitrendipine by bepridil.
Balwierczak JL; Grupp IL; Grupp G; Schwartz A
J Pharmacol Exp Ther; 1986 Apr; 237(1):40-8. PubMed ID: 2937911
[TBL] [Abstract][Full Text] [Related]
30. Voltage-sensitive nitrendipine binding in an isolated cardiac sarcolemma preparation.
Schilling WP; Drewe JA
J Biol Chem; 1986 Feb; 261(6):2750-8. PubMed ID: 3005262
[TBL] [Abstract][Full Text] [Related]
31. Characterization of verapamil binding sites in cardiac membrane vesicles.
Garcia ML; Trumble MJ; Reuben JP; Kaczorowski GJ
J Biol Chem; 1984 Dec; 259(24):15013-6. PubMed ID: 6096353
[TBL] [Abstract][Full Text] [Related]
32. [3H]nitrendipine binding in the guinea pig left ventricle: effects of calcium and lanthanum.
Fawzi AB; McNeill JH
Eur J Pharmacol; 1984 Sep; 104(3-4):357-62. PubMed ID: 6437849
[TBL] [Abstract][Full Text] [Related]
33. Characterization and solubilization of the nitrendipine binding protein from canine small intestinal circular smooth muscle.
Salter F; Grover AK
Cell Calcium; 1987 Apr; 8(2):145-55. PubMed ID: 3594555
[TBL] [Abstract][Full Text] [Related]
34. Local anesthetics differentiate dihydropyridine calcium antagonist binding sites in rat brain and cardiac membranes.
Bolger GT; Marcus KA; Daly JW; Skolnick P
J Pharmacol Exp Ther; 1987 Mar; 240(3):922-30. PubMed ID: 3031279
[TBL] [Abstract][Full Text] [Related]
35. [3H]-Nimodipine and [3H]-nitrendipine as tools to directly identify the sites of action of 1,4-dihydropyridine calcium antagonists in guinea-pig tissues. Tissue-specific effects of anions and ionic strength.
Bellemann P; Ferry D; Lübbecke F; Glossmann H
Arzneimittelforschung; 1982; 32(4):361-3. PubMed ID: 7201804
[TBL] [Abstract][Full Text] [Related]
36. Characterization of the binding of [3H]SR 33805 to the slow Ca2+ channel in rat heart sarcolemmal membrane.
Chatelain P; Dewinkeleer P; Beaufort P; Meysmans L; Clinet M
Eur J Pharmacol; 1994 Apr; 267(2):151-60. PubMed ID: 8050476
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of 3H-nitrendipine binding in rat aortic and cerebral cortex membranes by the new dihydropyridine calcium antagonist benidipine hydrochloride.
Ishii A
Arzneimittelforschung; 1989 Dec; 39(12):1546-50. PubMed ID: 2624603
[TBL] [Abstract][Full Text] [Related]
38. Interaction of 1,4 dihydropyridine calcium channel antagonists with biological membranes: lipid bilayer partitioning could occur before drug binding to receptors.
Herbette LG; Vant Erve YM; Rhodes DG
J Mol Cell Cardiol; 1989 Feb; 21(2):187-201. PubMed ID: 2545886
[TBL] [Abstract][Full Text] [Related]
39. Relationship between steady-state depression of calcium-dependent action potentials and competition for binding sites by nifedipine, nitrendipine, and PY 108-068.
Bagwell EE; Serafino R; Hungerford RT; Lindenmayer GE
J Cardiovasc Pharmacol; 1987 Dec; 10(6):707-15. PubMed ID: 2450242
[TBL] [Abstract][Full Text] [Related]
40. Specific binding of a calcium channel activator, [3H]BAY k 8644, to membranes from cardiac muscle and brain.
Janis RA; Rampe D; Sarmiento JG; Triggle DJ
Biochem Biophys Res Commun; 1984 May; 121(1):317-23. PubMed ID: 6203531
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
